Cedar Pine
- 27/09/2022
- Series D
- $250,000,000
Cedar Pine is a private investment firm specializing in strategic, long-term assets. Headquartered near Chicago, Cedar Pine’s team strives to create value by applying and building on decades of unique expertise as operators and investors in healthcare, finance, and real estate. Cedar Pine is not an investment adviser and does not accept outside capital.
- Industry Investment Management
- Website https://www.cedarpine.com/
- LinkedIn https://www.linkedin.com/company/cedar-pine/
Related People
Derek MazurInvestor
I studied biology in school to appreciate the little things in life, and business to further realize technological potential through investments.
Currently I am an investor at Cedar Pine, one of the largest family offices in the US. My mandate, while healthcare forward, is ultimately industry agnostic, and focused primarily on private company opportunities including venture capital, growth capital, and select buyout investments. We seek to write $25M or more into privately held enterprises as a lead, co-lead, or co-investor.
Previously, I spent time as an investor and operator at Paragon Biosciences, a company building platform. At Paragon, I launched a regenerative medicine company, and held a number of senior business development functions across the portfolio, which included the sourcing of new assets as well as leading divestiture efforts. During my time at Paragon, the firm had invested over $1.5BN into its portfolio companies to date.
Prior to Paragon, I was with Santé Ventures, a top quartile life science venture capital and machine learning hedge fund with over $1BN under management.
In a more distant life, I was also an investment banker, which I leverage from time-to-time to help remind me how to spell "revenue" and "EBITDA" despite my venture capital history.
Please feel free to reach out if you are interested in connecting.